Fürst T, Keiser J, Utzinger J, 2012. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 12: 210–221.
Yen TJ, Hsiao CH, Hu RH, Liu KL, Chen CH, 2011. Education and imaging: hepatobiliary and pancreatic: chronic hepatic abscess associated with fascioliasis. J Gastroenterol Hepatol 26: 611.
Arslan F, Batirel A, Samasti M, 2012. Fascioliasis: 3 cases with three different clinical presentations. Turk J Gastroenterol 23: 267–271.
Apt W, Aguilera X, Vega F, Miranda C, Zulantay I, Perez C, Gabor M, Apt P, 1995. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 52: 532–535.
Marcos LA, Tagle M, Terashima A, Bussalleu A, Ramirez C, Carrasco C, Valdez L, Huerta-Mercado J, Freedman DO, Vinetz JM, 2008. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis. Am J Trop Med Hyg 78: 222.
Kaya M, Beştaş R, Cetin S, 2011. Clinical presentation and management of Fasciola hepatica infection: single-center experience. World J Gastroenterol 28: 4899–4904.
Rashed AA, Khalil HH, Morsy AT, 2010. Zoonotic ectopic fascioliasis: review and discussion. J Egypt Soc Parasitol 40: 591–608.
Apt W, Aguilera X, Vega F, Miranda C, Zulantay I, Perez C, Gabor M, Apt P, 1995. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 52: 532–534.
Espinoza JR, Maco V, Marcos L, Saez S, Neyra V, Terashima A, Samalvides F, Gotuzzo E, Chavarry E, Huaman MC, Bargues MD, Valero MA, Mas-Coma S, 2007. Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg 76: 977–982.
Hillyer GV, Soler de Galanes M, Rodriguez-Perez J, Bjorland J, Silva de Lagrava M, Ramirez Guzman S, Bryan RT, 1992. Use of the Falcon assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg 46: 603.
Carnevale S, Rodriguez MI, Santillan G, Labbe JH, Cabrera MG, Bellegarde EJ, Velasquez JN, Trgovcic JE, Guarnera EA, 2001. Immunodiagnosis of human fascioliasis by an enzymelinked immunosorbent assay (ELISA) and a micro-ELISA. Clin Diagn Lab Immunol 8: 174–177.
World Health Organization Fascioliasis, 2009. Infection with the “Neglected” Neglected Worms. Available at: http://www.who.int/neglected_diseases/integrated_media/integrated_media_fascioliasis/en/index.html. Accessed June 4, 2011.
|Past two years||Past Year||Past 30 Days|
|Full Text Views||371||149||2|
Fascioliasis is a zoonotic infestation caused by the trematode fasciola hepatica. It presents a wide spectrum of clinical pictures ranging from fever and eosinophilia to ambiguous gastrointestinal symptoms in the acute phase. However, it may often be overlooked, especially in the acute phase, because of uncertain symptoms. Fasciola hepatica can have an initial presentation similar to the presentation of malignancy. Here, we report a case of a hepatic mass caused by fasciola hepatica.
Authors' addresses: Bülent Yılmaz and Seyfettin Köklü, Department of Gastroenterology, Hacettepe University School of Medicine, Ankara, Turkey, E-mails: firstname.lastname@example.org and email@example.com. Gökhan Gedikoğlu, Department of Pathology, Hacettepe University School of Medicine, Ankara, Turkey, E-mail: firstname.lastname@example.org.